Effect of Desmopressin on Platelet Dysfunction During Antiplatelet Therapy: A Systematic Review.
Lise Kjær AndersenAnne-Mette HvasChristine Lodberg HvasPublished in: Neurocritical care (2020)
The present data hold biochemical evidence that DDAVP improves platelet function during antiplatelet therapy in humans and animals. The need for randomized trials is evident in order to evaluate the potential clinical effect of DDAVP in management of patients with spontaneous or traumatic hemorrhage, or undergoing neurosurgery, while receiving antiplatelet therapy.